Article thumbnail

Lenalidomide induced good clinical response in a patient with multiple relapsed and refractory Hodgkin's lymphoma

By Inga Mandac and Slobodanka Ostojic Kolonic
Topics: Letter to the Editor
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2893445
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2009). Ervin-Haynes A, Zeldis JB, Vose JM: Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's lymphoma.
  2. (2010). Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma. Br J Haematol
  3. NL: A phase II multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma [abstract].
  4. (2008). TM: Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.